Helminth parasites induce a strong Th2 response, characterized by high levels of IgE and elevated signature cytokines such as IL-5. As many global deworming programmes are underway, there is concern that this might lead to emergence of Th1-mediated pathologies when the counterbalancing helminth-induced Th2 response is absent. Therefore, we assessed the effect of deworming on Th2-mediated responses in a household-clustered randomized controlled trial in Indonesia. Total plasma IgE and whole-blood IL-5 responses to mitogen phytohaemagglutinin (PHA) were measured in 1494 and 682 subjects, respectively, at baseline, 9 and 21 months after three-monthly single-dose treatment with albendazole or placebo. Anthelmintic treatment did not result in complete removal of helminth infections in the community. However, treatment significantly decreased IgE levels in albendazole-compared to placebo-treated subjects. IL-5 responses to PHA were not significantly affected by anthelmintic treatment and tended to increase in albendazole-treated subjects, indicating that intensive treatment of helminth parasites has different outcomes on B-cell (IgE levels) and T-cell (IL-5) responses. The data shows that 2 years of deworming can have differential effects on responses typified as Th2-mediated, which needs to be taken into account when examining the impact of helminths on noncommunicable diseases.
single-dose treatment with albendazole or placebo. Anthelmintic treatment did not result in complete removal of helminth infections in the community. However, treatment significantly decreased IgE levels in albendazole-compared to placebo-treated subjects. IL-5 responses to PHA were not significantly affected by anthelmintic treatment and tended to increase in albendazole-treated subjects, indicating that intensive treatment of helminth parasites has different outcomes on B-cell (IgE levels) and T-cell (IL-5) responses. The data shows that 2 years of deworming can have differential effects on responses typified as Th2-mediated, which needs to be taken into account when examining the impact of helminths on noncommunicable diseases. Th2 responses were associated with improved glucose metabolism and insulin signalling in mice. [3] [4] [5] [6] This has raised concern regarding the implementation of deworming programmes, which might lead to emergence of Th1-mediated pathologies. The immunological consequences of deworming should therefore be examined in detail, given that Th2 responses consist of multiple arms.
To this end, we analysed the immunological data obtained from a household-based cluster-randomized double-blind placebo-controlled trial of three-monthly single-dose albendazole treatment in an area where STHs are highly endemic. 7 This study describes the effect of anthelmintic treatment on two different components of the Th2 response, namely total IgE levels and total IL-5 production in response to a polyclonal stimulation (phytohemagglutinin, PHA).
| MATERIALS AND METHODS

| Study design
This report describes a nested study within the ImmunoSPIN trial.
8,9
The trial was conducted in 2 villages, Nangapanda and Anaranda, 
| Study population
The randomization for the total study was based on 954 households comprising of 4 004 individuals in the 2 villages, resulting in 2 022
(481 houses) and 1 982 (473 houses) subjects in the placebo and albendazole group, respectively, as described before. 7 The current study included 1 762 (363 houses) and 1 731 (362 houses) subjects in the placebo and albendazole group in the village of Nangapanda respectively (Fig. S1 ). At baseline, blood samples from 2 349 subjects were collected to analyse total IgE levels and after inclusion of subjects with at least one follow-up blood sample, 1 494 subjects were included at baseline, corresponding to 753 placebo-and 741 albendazole-treated individuals.
To study immunological responses, 250 households were randomly selected and individuals older than 4 years of age were invited for morning venous blood sampling and assessment of anthropometric parameters. This resulted in the inclusion of 882 individuals, of which 858 provided sufficient blood samples for whole-blood cultures. After inclusion of subjects with at least baseline and one follow-up blood sample, we ended up with 682 subjects at baseline, corresponding to 374 placebo-and 308 albendazole-treated individuals (Fig. S1 ). As this is a nested immunology study, 86% (584 of 682) of the subjects were also part of the group of 1 494 subjects included for the analysis of IgE levels.
| Parasitological examination
Yearly stool samples were collected to examine the effect of treatment on helminth prevalence. T. trichiura was detected by micros- T. trichiura of which only microscopy data were available. A subject was defined to have a heavy infection when a high DNA load (Ct<30) was measured for either hookworm or A. lumbricoides, whereas a light infection refers to subjects with low DNA loads (Ct≥30) for both of these helminth species, including subjects that are helminth negative.
| Plasma IgE
The levels of total IgE were measured by ELISA in Jakarta as described previously. 9 The results are expressed in international units (IU/mL).
| Whole-blood culture and IL-5 measurements
Whole blood was stimulated in vitro as described before. 9,10 Cultures were stimulated for 72 hours to detect adaptive responses to phytohaemagglutinin (PHA, 2 μg/mL, Wellcome Diagnostics, Dartford, UK), and unstimulated control wells were included. Due to budget restrictions, we could only measure one Th2 cytokine and opted for IL-5.
Supernatants were stored at −20°C until IL-5 was quantified using
Luminex cytokine kits (Biosource, Camarillo, USA) on a LiquiChip
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Cytokine levels that fell below the assay's detectable range were replaced by half of the detection limit provided by the manufacturer.
| Statistical analysis
The total IgE and cytokine data were log-transformed to obtain a normally distributed variable. Cross-sectional comparisons between groups at baseline were tested with Student's t test. To assess treatment effects, generalized linear mixed models were used with addition of three random effects, namely a random household-specific intercept to model clustering within households and a random subjectspecific intercept and slope to model correlation within subjects, as previously described. 10 Parameter estimates for treatment effects at 9 and 21 months and 95% confidence intervals are reported, as well as interaction P-values when a subgroup analysis was performed. The reported P-values are obtained using likelihood ratio tests by comparing the model with and without the treatment effect. All models were fitted using the lme4 package. 11 The analysis was intention to treat and involved all participants as assigned randomly at the start of the trial.
| RESULTS
| Study population
Baseline characteristics of the study participants are shown in Table 1 .
At baseline, 84.8% of the individuals were infected with one or more helminth species, with hookworm infections being the most prevalent (73.1% of total). At baseline, total IgE levels and IL-5 production in response to PHA were similar in both treatment arms. The consort diagram of the study is shown in Fig. S1 . Subjects were included in the analysis when data from baseline and at least one of the two follow-up time points were available.
| Effect of albendazole treatment on helminth prevalence
Similar to the major study, 7 subset analysis in this study revealed that in- Figure 1B presents the estimated effect of treatment on total IgE levels after 9 and 21 months. Total IgE levels were significantly lower were taken into account, the overall P-value over time fell short of statistical significance (P time =.146). IL-5 measured in unstimulated blood revealed no treatment-related differences (data not shown).
| Baseline IgE levels
| Effect of albendazole treatment on plasma IgE levels
Additionally, we observed no effect of treatment on IL-5, nor differences in the treatment effect between subgroups when subjects with light and heavy infections (P-value for interaction=.850) or children and adults (P-value for interaction=.998) were analysed sepa- F I G U R E 1 Effect of deworming on the prevalence of helminth infections, total IgE levels and whole-blood IL-5 production in response to phytohaemagglutinin (PHA).
(A) Percentage of helminth-infected subjects in placebo-and albendazoletreated arms. The estimated effect of albendazole treatment on plasma total IgE levels (B) and IL-5 production in response to PHA in supernatant of 72 h-stimulated whole-blood cultures (C) is displayed for the 9-and the 21-month time points, with corresponding 95% confidence intervals. The estimates of the treatment effect were obtained by general linear mixed models and overall P-values over time are indicated.
| DISCUSSION
This is the first time that the effects of long-term placebo-controlled anthelmintic treatment on different components of a helminthinduced Th2 response have been analysed in a whole community. We show a significant decline in plasma IgE levels in albendazole-treated subjects over a period of 21 months compared to placebo-treated subjects. However, whereas both IgE and IL-5 are important products of the helminth-induced Th2 response, IL-5 production by peripheral blood cells in response to PHA was not significantly affected by anthelmintic treatment and rather tended to increase.
It is well known that helminth parasites are potent inducers of IgE production. [12] [13] [14] [15] So far, only a few longitudinal studies have been performed to study the effect of anthelmintic treatment on polyclonal IgE levels. [16] [17] [18] In line with our findings, Cooper et al. 14 showed that 1 year of anthelmintic treatment was associated with a significant reduction in total IgE levels in children, suggesting that current STH infections are important determinants of IgE levels. Whereas previous studies only included children below 12 years of age, 14, 16 in the current randomized trial, we studied the general population across all ages to
show decreases in IgE levels in the whole community irrespective of age.
Overall, the treatment effect on IgE was seen at 9 months, and this effect remained at 21 months and IgE levels did not further decrease.
The major effect seen on IgE after 9 months probably reflects the large decrease in prevalence of hookworm and A. lumbricoides which was 2.5-and 2.3-fold compared to baseline, respectively, whereas after 21 months, the prevalence of both species decreased 1.4-fold compared to 9 months post-treatment. The lack of further decrease in IgE at 21 months may be due to continued exposure to incoming parasites in a contaminated environment, which would stimulate long-lived IgE plasma cells contributing to sustained IgE antibody production.
14,19
Given the observed treatment effect on IgE, it would appear that deworming decreases Th2-mediated responses. However, we found no significant effect of treatment on IL-5 in response to PHA and even a trend towards increase at 21 months post-treatment. As described elsewhere in more detail, 10 analysis of uninfected subjects showed that treatment had no effect on IL-5 production, ruling out a direct ef- responses to worm antigens were increased in subjects who remained free from infection 2 years after helminth clearance, compared to subjects who became re infected. 22 This enhanced cytokine response can be due to either removal of the immunosuppressive effects of active infection or immunological boosting by antigens released from dying parasites. 23 Although it is possible that treatment boosts the antigen-specific responses, often also responses to unrelated antigens such as PHA are enhanced by anthelmintic treatment. The latter cannot be explained by helminth antigens boosting specific T-cell responses, unless it is due to cross-reactive antigen responses that are enhanced in these unrelated antigens.
10,21
As anthelmintic treatment appears to have opposite effects on type 2 cytokine production and total IgE, and IL-4 and IL-13 promote IgE production, this raises the question whether there are IL-4/IL-13 independent pathways of IgE regulation. T-cell-independent IgE + Bcell maturation in tissues has been described, suggesting that IgE class switching does not fully depend on Th2 cytokine levels. 24 26 In humans, the frequencies of total and activated peripheral memory Tfh cells were found to be significantly increased during S. japonicum infection. 27 Although it is currently unknown what happens to Tfh cell numbers after helminth clearance, decreasing numbers could possibly explain the observed decline in total IgE after treatment, as this would lead to less IL-4 production in B-cell follicles, hence less IgE secretion.
Based on our findings, we could conclude that 2 years of anthelmintic treatment might have differential effects on Th2 responses. IgE responses are elevated in helminth-infected subjects and decline after intensive deworming, whereas IL-5 production by peripheral blood cells seems suppressed in infected subjects and might be reversed after deworming. Both phenomena have separately been reported by others, and here we report the occurrence of both within one community. These differential effects on responses typified as Th2-mediated need to be taken into account when examining the effects of helminths on noncommunicable diseases. The concern that upon deworming, inflammatory diseases such as allergies could increase, might be justified if we look at Th2 cytokines, but not if one considers IgE. However, it is also known that IgE responses during helminth infection are dominated by antibodies that have poor biological activity 28 and therefore, a decrease in IgE that is not functional might still be in line with a relative increase in IgE that can trigger mast cell degranulation.
It would be interesting to complement these findings with data on eosinophilia and other Th2 cytokine responses such as IL-4 and IL-13, in order to further investigate helminth's immunomodulatory effects on Th2 responses.
